NCT00593879View on ClinicalTrials.gov

Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder

PHASE2CompletedINTERVENTIONAL

Enrollment

450

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

August 31, 2006

Conditions

Major Depressive Disorder

Interventions

DRUG

Mecamylamine

2.5mg mecamylamine Hcl, tablet form taken twice a day (total of 5.0mg). For 7.5 mg dose group, 2 tablets taken morning, one tablet evening. At 10.0mg, 2 tablets taken twice daily.

All Listed Sponsors

lead

Targacept Inc.

INDUSTRY

NCT00593879 - Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder | Biotech Hunter | Biotech Hunter